From: The burden of leukemia in the Kingdom of Saudi Arabia: 15 years period (1999–2013)
Variables | Male | Female | Total | |||
---|---|---|---|---|---|---|
Morphology | No. | % | No. | % | No. | % |
Precursor B-cell lymphoblastic leukemia | 934 | 18.7 | 696 | 18.7 | 1,630 | 18.7 |
Precursor cell lymphoblastic leukemia, NOS | 875 | 17.6 | 630 | 16.9 | 1,505 | 17.3 |
Chronic myeloid leukemia, NOS | 575 | 11.5 | 556 | 14.9 | 1,131 | 13.0 |
Acute myeloid leukemia, NOS | 554 | 11.1 | 486 | 13.0 | 1,040 | 11.9 |
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma | 499 | 10.0 | 251 | 6.7 | 750 | 8.6 |
Precursor T-cell lymphoblastic leukemia | 256 | 5.1 | 67 | 1.8 | 323 | 3.7 |
Acute promyelocytic leukemia, t(15;17)(q22;q11–12) | 155 | 3.1 | 160 | 4.3 | 315 | 3.6 |
Acute monocytic leukemia | 125 | 2.5 | 109 | 2.9 | 234 | 2.7 |
Leukemia, NOS | 129 | 2.6 | 89 | 2.4 | 218 | 2.5 |
Acute leukemia, NOS | 99 | 2.0 | 99 | 2.7 | 198 | 2.3 |
Acute myelomonocytic leukemia | 94 | 1.9 | 105 | 2.8 | 199 | 2.3 |
Acute myeloid leukemia with maturation | 83 | 1.7 | 83 | 2.2 | 166 | 1.9 |
Acute myeloid leukemia without maturation | 50 | 1.0 | 53 | 1.4 | 103 | 1.2 |
Chronic myelogenous leukemia, BCR/ABL positive | 59 | 1.2 | 48 | 1.3 | 107 | 1.2 |
All others | 497 | 10.0 | 296 | 7.9 | 793 | 9.1 |